Presently available serum markers of cardiac injury, such as the troponins, were developed as extensions of studies of these candidate proteins in basic cardiac physiology. In this proposal, we will test the following hypotheses: 1) That analysis of serum proteins from patients undergoing """"""""planned myocardial infarction (PMI),"""""""" using unbiased proteomics technologies, will lead to the discovery of both novel markers of cardiac injury and novel serum response proteins which shed insight onto disease pathogenesis; 2) That novel markers and response proteins discovered in the setting of PMI will be valid in a heterogeneous population of myocardial infarction (MI) patients; and 3) That levels of novel markers and response proteins discovered in PMI will predict clinical outcomes in the heterogeneous MI population. Towards the goal of developing new cardiac markers, we first characterized serum from patients undergoing an alcohol septal ablation for hypertrophic cardiomyopathy, an in vivo model of human MI. In this population, we have identified peptide spectra and specific proteins that appear in the serum after myocardial injury. However, findings from this controlled patient subset must be validated in a heterogeneous patient cohort. Therefore, we will apply our preliminary data from the PMI group to the CLARITY-TIMI 28 trial, a large, double-blind, randomized clinical trial studying patients with acute ST elevation myocardial infarction (STEMI).
In Specific Aim 1, we will characterize the recently identified peptide markers in the entire cohort of PMI patients.
In Specific Aim 2, we will validate the novel markers in a diverse patient population of """"""""normal myocardial infarction"""""""" in the TIMI trial.
In Specific Aim 3, we will correlate elevations in novel protein markers and response proteins with outcomes in patients with acute MI in the TIMI trial.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL072872-04
Application #
6929965
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S2))
Program Officer
Desvigne-Nickens, Patrice
Project Start
2002-09-25
Project End
2007-07-31
Budget Start
2005-08-01
Budget End
2007-07-31
Support Year
4
Fiscal Year
2005
Total Cost
$389,250
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Ganda, Anjali; Magnusson, Martin; Yvan-Charvet, Laurent et al. (2013) Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis. Circulation 127:988-96
Lewis, Gregory D; Farrell, Laurie; Wood, Malissa J et al. (2010) Metabolic signatures of exercise in human plasma. Sci Transl Med 2:33ra37
Lewis, Gregory D; Gerszten, Robert E (2010) Toward metabolomic signatures of cardiovascular disease. Circ Cardiovasc Genet 3:119-21
Baumgartner, Christian; Lewis, Gregory D; Netzer, Michael et al. (2010) A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury. Bioinformatics 26:1745-51
Lewis, Gregory D; Wei, Ru; Liu, Emerson et al. (2008) Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118:3503-12
Lewis, Gregory D; Asnani, Aarti; Gerszten, Robert E (2008) Application of metabolomics to cardiovascular biomarker and pathway discovery. J Am Coll Cardiol 52:117-23
Sabatine, Marc S; Morrow, David A; McCabe, Carolyn H et al. (2006) Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable angina and non-ST-elevation myocardial infarction. Am Heart J 151:25-31
Sabatine, Marc S; Morrow, David A; Giugliano, Robert P et al. (2005) Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 111:2042-9
Sabatine, Marc S; Liu, Emerson; Morrow, David A et al. (2005) Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112:3868-75
Chen, A A; Sabatine, M S (2003) The management of unstable angina and non-ST-segment elevation myocardial infartion. Minerva Cardioangiol 51:433-45